Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today announced a poster presentation at the 12th International Congress of Inborn Errors of Metabolism (ICIEM) conference being held in Barcelona, Spain, September 3-6, 2013.
Help employers find you! Check out all the jobs and post your resume.
